Views & Analysis | Perspectives on pharma industry issues

Digital

Two female silhouettes in a city office overlook the urban landscape below

How female leadership can benefit industry

Day One Strategy’s founding partners Abigail Stuart and Hannah Mann share the benefits female leadership can bring to industry.

Patients

Maintenance: The underexamined half of the GLP-1 story

GLP-1 treatments have historically had an exit problem, as appetite suppression stops when the medication stops.

Oncology

pharmaphorum podcast Episode 276, Irina Babina, Concr

Getting predictive technologies to patients, with Concr

Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.

R&D

Concept of AI overview of patient in clinical trial

How AI simulation could help de-risk obesity and cardiometab...

AI life sciences models allow researchers to explore different patient populations, protocols, and development strategies before a study starts.

Sales & Marketing

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

Articles

What about the clinical research sites in Latin America?

Valentina Jaramillo provides an overview of the current environment of clinical research sites in Latin America. There have been discussions for a while now on the importance of developing countries in clinical research and I think it is pretty clear by now that all developing...

Articles

Why pharma clinical development must go beyond its means

Chris Fidyk takes a look at the history of the pharmaceutical industry, with regards to clinical trials legislation and how it has evolved over the years. As the American healthcare system marches slowly, but steadily, away from its fee-for-service roots towards a fee-for-value future...

Articles

Pharma gets social – LillyPad provides platform for Lilly's ...

In his latest article, Daniel Ghinn explores the processes behind the launch of LillyPad and speaks with Greg Kueterman, from Lilly, on his experiences in getting the regulatory team on board and looking after the social media channels. It is almost two years since Lilly took its first deliberate steps into corporate engagement via social media with the launch of its...

Sales & Marketing

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

Sales & Marketing

The patient communication crisis pharma can no longer ignore

Industry's significant investments in patient engagement are only effective if patients trust the communication enough to answer in the first place.

Digital

How female leadership can benefit industry

Day One Strategy’s founding partners Abigail Stuart and Hannah Mann share the benefits female leadership can bring to industry.

Digital

Pharma brands face golden opportunity to extend supply chain...

People are ready for technology that verifies authenticity and provides helpful information directly from the medicinal product itself.

Market Access

$100 notes in pill bottle on aquamarine background with spilled pills

How new PBM transparency rules will alter drug pricing

The complex drug pricing ecosystem means all stakeholders are scrambling to understand how the new regulations and PBMs’ adjustments will impact them.

Market Access